Switch to fixeddose doravirine 100 mg with islatravir 075 mg once daily in virologically suppressed adults with HIV1 on bictegravir emtricitabine and tenofovir alafenamide 48week results of a phase 3 randomised controlled doubleblind noninferiority t

J MolinaGiuliano RizzardiniC OrrellA AfaniA CalmyE et al2025-03-14WOS2352-3018https://hdl.handle.net/10539/44299Switch to fixeddose doravirine 100 mg with islatravir 075 mg once daily in virologically suppressed adults with HIV1 on bictegravir emtricitabine and tenofovir alafenamide 48week results of a phase 3 randomised controlled doubleblind noninferiority tJournal Article